共 50 条
Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma
被引:25
|作者:
Lin, Ching-Jung
[1
]
Hsu, Teh-Fu
[1
,2
,3
]
Chang, Yen-Hou
[1
,3
]
Huang, Ben-Shian
[1
,3
,4
]
Jiang, Ling-Yu
[1
,3
]
Wang, Peng-Hui
[1
,3
,4
]
Chen, Yi-Jen
[1
,3
,4
,5
]
机构:
[1] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Emergency Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[5] Cheng Hsin Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
来源:
关键词:
Adenomyosis;
Adenomyoma;
Conservative uterine-sparing surgery;
Gonadotropin releasing hormone agonist;
Levonorgestrel-releasing intrauterine system;
MEDICAL-TREATMENT;
AND/OR ADENOMYOMA;
PELVIC PAIN;
THERAPY;
TRIAL;
WOMEN;
D O I:
10.1016/j.tjog.2017.12.036
中图分类号:
R71 [妇产科学];
学科分类号:
100211 ;
摘要:
Objective: To evaluate whether a maintenance levonorgestrel-releasing intrauterine system is effective for preventing the recurrence of postoperative adenomyosis-related symptoms. Materials and methods: From January 2005 through December 2014, a retrospective study including 133 patients with symptomatic adenomyosis undergoing conservative uterine-sparing surgery followed by gonadotropin-releasing hormone agonist treatment was conducted. We excluded the 18 patients who did not meet the inclusion criteria. The patients of intervention group (n = 54) received a levonorgestrelreleasing intrauterine system (LNG-IUS), which was inserted after surgery. The patients without LNG-IUS insertion were enrolled in the control group (n = 61). The primary outcome was improvement of adenomyosis-related dysmenorrhea, which was evaluated by the visual analog scale (VAS) and by hemoglobin (Hgb) and CA-125 levels. Results: Over a 12-month follow-up, the intervention group exhibited a greater reduction in dysmenorrhea as assessed with a VAS score (mean +/- SD: 6.5 +/- 2.5 vs 4.1 +/- 3.6, p = 0.001) and a greater elevation in the Hgb level (2.1 +/- 1.9 vs 1.0 +/- 1.7, p = 0.008) than the control group. At the end of the 24-month follow-up period, the intervention group also exhibited a greater reduction in dysmenorrhea as assessed with a VAS score (mean +/- SD 6.1 +/- 2.7 vs 3.7 +/- 3.7, p = 0.002) and a greater elevation in the Hgb level (1.9 +/- 2.1 vs 0.7 +/- 1.8, p = 0.022) than the control group. The CA-125 level was significantly lower in the intervention group during the postoperative follow up (12th month follow-up, intervention vs control, 24.5 +/- 28.8 vs 50.1 +/- 44.0, p = 0.005; 24th month follow-up, 28.6 +/- 26.2 vs 75.4 +/- 68.5, p = 0.002). Conclusion: The maintenance therapy of LNG-IUS is effective and well accepted for long-term therapy after conservative surgery for patients with adenomyosis. (C) 2018 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.
引用
收藏
页码:47 / 51
页数:5
相关论文